ReShape Lifesciences Inc. Annual Return On Assets in % from 2017 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
ReShape Lifesciences Inc. quarterly/annual Return On Assets history and growth rate from 2017 to 2024.
  • ReShape Lifesciences Inc. Return On Assets for the quarter ending December 31, 2024 was -114 %, a 16.8% decline year-over-year.
  • ReShape Lifesciences Inc. annual Return On Assets for 2024 was -114 %, a 16.8% decline from 2023.
  • ReShape Lifesciences Inc. annual Return On Assets for 2023 was -97.6 %, a 34.8% increase from 2022.
  • ReShape Lifesciences Inc. annual Return On Assets for 2022 was -150 %, a 66.2% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -114 -16.4 -16.8% Jan 1, 2024 Dec 31, 2024
2023 -97.6 +52 +34.8% Jan 1, 2023 Dec 31, 2023
2022 -150 -59.6 -66.2% Jan 1, 2022 Dec 31, 2022
2021 -90 +15.4 +14.6% Jan 1, 2021 Dec 31, 2021
2020 -105 -7.33 -7.48% Jan 1, 2020 Dec 31, 2020
2019 -98 +8.59 +8.06% Jan 1, 2019 Dec 31, 2019
2018 -107 -50.5 -90% Jan 1, 2018 Dec 31, 2018
2017 -56.1 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.